Role of Anemia and Related Factors in Intentional Suicidal Attempts

Document Type : Original Article(s)

Authors

1 Associate Professor, Department of Anesthesiology, Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Associate Professor, Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

3 General Practitioner, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Background: One of the most common methods of suicide is acute poisoning. The association of anemia with psychiatric disorders and psychiatric disorders with suicidal behavior has been know previously. Due to the lack of study on relationship of anemia with suicide, anemia and related factors in intentional suicidal attempts were performed. Methods: A cross-sectional descriptive-analytic study was performed in Noor general hospital. 601 patients with attempted suicide self poisoning were evaluated. χ2 and logistic regression analysis was performed for data analysis. Finding: Prevalence of anemia was 33.8%. Frequency of anemia in patients according to age, sex and bipolar disorder showed significant differences. Logistic regression analysis showed the probability of suicide in women anemic patients was more than men (P = 0.022). Risk of suicide in anemic patients with bipolar disorder was 2.32 times the patients without bipolar disorder (P = 0.01). With increasing age of patients by age 60 relationship of anemia associated intentional poisoning would be increased. Conclusion: Gender, age and bipolar disorders are the related factor in patients with anemia and suicide.

Keywords

References

  1. Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abili-ties and in cerebral energy metabolism in adult rats. Behav Neurosci 1998; 112(5): 1199-208.
  2. Ishrat T, Khan MB, Hoda MN, Yousuf S, Ah-mad M, Ansari MA, et al. Coenzyme Q10 modu-lates cognitive impairment against intracerebro-ventricular injection of streptozotocin in rats. Behav Brain Res 2006; 171(1): 9-16.
  3. Hoyer S, Lannert H. Long-term effects of corti-costerone on behavior, oxidative and energy me-tabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracere-broventricular streptozotocin. J Neural Transm 2008; 115(9): 1241-9.
  4. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, et al. High-resolution PET studies in Alzheimer's disease. Neuropsycho-pharmacology 1991; 4(1): 35-46.
  5. Narita Y, Ohta S, Suzuki KM, Nemoto T, Abe K, Mishima S. Effects of long-term administration of royal jelly on pituitary weight and gene ex-pression in middle-aged female rats. Biosci Bio-technol Biochem 2009; 73(2): 431-3.
  6. Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 2002; 23(6): 288-93.
  7. Barker SA, Foster AB, Lamb DC, Hodgson N. Identification of 10-hydroxy-delta 2-decenoic acid in royal jelly. Nature 1959; 183(4666): 996-7.
  8. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S. Royal jelly-induced neurite out-growth from rat pheochromocytoma PC12 cells requires integrin signal independent of activation of extracellular signal-regulated kinases. Biomed Res 2007; 28(3): 139-46.
  9. Hashimoto M, Kanda M, Ikeno K, Hayashi Y, Nakamura T, Ogawa Y, et al. Oral administra-tion of royal jelly facilitates mRNA expression of glial cell line-derived neurotrophic factor and neurofilament H in the hippocampus of the adult mouse brain. Biosci Biotechnol Biochem 2005; 69(4): 800-5.
  10. Donadieu Y. Royal Jelly in Natural Therapeutics. 6th ed. Paris: Rue de l'Ecole de Medecine; 1983.
  11. Hattori N, Nomoto H, Mishima S, Inagaki S, Goto M, Sako M, et al. Identification of AMP N1-oxide in royal jelly as a component neu-rotrophic toward cultured rat pheochromocyto-ma PC12 cells. Biosci Biotechnol Biochem 2006; 70(4): 897-906.
  12. Zamami Y, Takatori S, Goda M, Koyama T, Iwatani Y, Jin X, et al. Royal jelly ameliorates insulin resistance in fructose-drinking rats. Biol Pharm Bull 2008; 31(11): 2103-7.
  13. Nagai T, Inoue R, Suzuki N, Nagashima T. Anti-oxidant properties of enzymatic hydrolysates from royal jelly. J Med Food 2006; 9(3): 363-7.
  14. Narita Y, Nomura J, Ohta S, Inoh Y, Suzuki KM, Araki Y, et al. Royal jelly stimulates bone for-mation: physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Bio-chem 2006; 70(10): 2508-14.
  15. Hattori N, Ohta S, Sakamoto T, Mishima S, Fu-rukawa S. Royal Jelly Facilitates Restoration of the Cognitive Ability in Trimethyltin-Intoxicated Mice. Evid Based Complement Alternat Med 2009. [online].
  16. Paxinos G, Watson C. The Rat Brain in Stereo-taxic Coordinates. 4th ed. Maryland: Academic Press; 1998.
  17. Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S. Brain insulin system dys-function in streptozotocin intracerebroventricu-larly treated rats generates hyperphosphorylated tau protein. J Neurochem 2007; 101(3): 757-70.
  18. Kaur B, Singh N, Jaggi AS. Exploring mechanism of pioglitazone-induced memory restorative ef-fect in experimental dementia. Fundam Clin Pharmacol 2009; 23(5): 557-66.
  19. Rattray M. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol Psychiatry 2001; 49(3): 185-93.
  20. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S. Royal jelly and its unique fatty ac-id, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro. Biomed Res 2007; 28(5): 261-6.
Journal of Isfahan Medical School
Volume 29, Issue 132 - Serial Number 132
January and February 2011
Pages 304-311

Files

History

  • Receive Date: 23 May 2011
  • Revise Date: 01 June 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics